retatrutide and cagrilintide + Cagrilintide: Quad-Pathway Stack (2026) Stacking Retatrutide + Cagrilintide... Appetite

Treatment should only be continued if there has been a beneficial metabolic response, defined as a reduction in HbA1c of at least 11 mmol/mol (1.0%) and weight loss of at least 3% of initial body weight

4,5 Its antioxidant benefits make it a helpful option for supporting metabolic health, whether or not youre using GLP-1 medications.* 3

The most common side effects are gastrointestinal (nausea, diarrhea, vomiting, constipation, and indigestion), which are usually mild to moderate and dose-related

Supporting your GLP-1 production naturally isnt about perfectionits about nourishment, building consistency, and learning what works for your body

To help minimize this risk, your doctor might suggest lowering the dosage of insulin or sulfonylureas

For a detailed scientific overview of Retatrutide, including peptide structure, triple receptor pharmacology, HPLC purity, LC-MS testing and current published research, read our full educational guide